NHS labs fails to share data vital for diagnosis and care of rare diseases

Investigation finds variant sharing is inconsistent, incomplete, and in some cases absent Experts and families say this could be prolonging uncertainty and delaying treatment Three out of England’s seven NHS genetics laboratories are failing to routinely share vital information about genetic variants in public databases that helps patients with ...

2026-10-08T11:51:36+01:008 October 2026|Press release, The BMJ|

HPV vaccination before pregnancy linked to lower risk of preterm birth and other major complications

Greater risk reduction seen among women vaccinated at earlier ages Findings extend benefits of HPV vaccination beyond cancer prevention Having received the human papillomavirus (HPV) vaccine before pregnancy is associated with a lower risk of major pregnancy complications including preterm birth, with the greater reduction in risk seen among ...

2026-10-08T11:47:38+01:008 October 2026|Press release, The BMJ|

Robotic surgery offers no clear benefit over conventional joint replacement surgery

No differences in implant survival, revision risk or surgical complications when robotic surgery for hip and knee replacements were compared to conventional surgery Results question NHS plan for widespread adoption of robotics given substantially higher capital and procedural costs The NHS recently outlined plans to expand robotic surgery sevenfold ...

2026-10-01T11:41:51+01:001 October 2026|Press release, The BMJ|

Oral menopausal hormone therapy linked to higher blood clot risk in legs or lungs regardless of dose or duration

But stroke and heart attack risks limited to prolonged high-dose therapy, and no general increased risk seen with transdermal hormone therapy, findings show  Current use of oral menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is associated with an increased risk of blood clots in legs ...

2026-09-24T09:29:39+01:0024 September 2026|Press release, The BMJ|

GLP-1 and SGLT-2 diabetes drugs may help slow kidney damage

But little evidence of benefit seen among people without albuminuria The diabetes drugs glucagon-like peptide-1 (GLP-1) receptor agonists and sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs may also help to slow decline in kidney function in people with type 2 diabetes and albuminuria (high protein levels in the urine), ...

2026-09-16T15:28:04+01:0017 September 2026|Press release, The BMJ|
Go to Top